CN1172802A - [(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法 - Google Patents

[(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法 Download PDF

Info

Publication number
CN1172802A
CN1172802A CN97113612A CN97113612A CN1172802A CN 1172802 A CN1172802 A CN 1172802A CN 97113612 A CN97113612 A CN 97113612A CN 97113612 A CN97113612 A CN 97113612A CN 1172802 A CN1172802 A CN 1172802A
Authority
CN
China
Prior art keywords
alkyl
methyl
phenyl
hydrogen
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN97113612A
Other languages
English (en)
Other versions
CN1100758C (zh
Inventor
吴文雪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CN1172802A publication Critical patent/CN1172802A/zh
Application granted granted Critical
Publication of CN1100758C publication Critical patent/CN1100758C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明提供了制备结构式Ⅰ的[(5,6-二羧基-3-吡啶基)甲基]卤化铵的方法[(5,6-二羧基-3-吡啶基)甲基]卤化铵是制备除草剂5-(烷氧基甲基)-2-(2-咪唑啉-2-基)-烟酸、酯、盐化合物中有用的中间体。

Description

[(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法
本发明涉及[(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法。
[(5,6-二羧基-3-吡啶)甲基]卤化铵是制备除草剂5-(烷氧基甲基)-2-(2-咪唑啉-2-基)烟酸、酯和盐化合物中有用的中间体。美国专利5,378,834揭示了将5-甲基-2,3-吡啶二羧酸衍生物转化为[(5,6-二羧基-3-吡啶)甲基]卤化铵的方法。虽然该专利的方法是有用的,人们尚在努力发现制备[(5,6-二羧基-3-吡啶)甲基]卤化铵的新方法。
因此,本发明的一个目的是提供制备[(5,6-二羧基-3-吡啶)甲基]卤化铵的高效的方法。
本发明提供了制备结构式I的[(5,6-二羧基-3-吡啶)甲基]卤化铵的高效方法:
Figure A9711361200051
其中R、R1和R2各自是C1-C4烷基,当结合在一起时,R和R1可形成任意被O、S或NR3间隔的5-元或6-元环;
R3是C1-C4烷基,
X是Cl、Br或I;
Z是氢或卤素;和
Z1是氢、卤素、氰基或硝基,
该方法包括在碱水溶液存在下用过氧化氢使结构式II的取代的(3-喹啉基甲基)卤化铵氧化
Figure A9711361200061
其中R、R1、R2、X、Z和Z1的定义与上式I的相同;
R4、R5、R6和R7各自是氢、羟基、硝基、OC(O)R8、卤素、NR9R10、C1-C4烷氧基、SO3H、SO2C1或SH,条件是R4、R5、R6和R7中的一个不是氢或卤素;
R8是C1-C4烷基、C1-C4烷氧基、苯基或NR11R12
R9、R10、R11和R12各自是氢、C1-C4烷基或苯基;
它的N-氧化物;和
它的酸加成盐。
在本发明一个较好的技术方案中,式II代表的取代的(3-喹啉基甲基)卤化铵用至少约8摩尔当量的过氧化氢在至少约1摩尔当量,较好的是约4-10摩尔当量碱水溶液存在下,较好地在约50-100℃温度范围下,更好地在约75-95℃温度范围下进行氧化。
现已发现,有利的是通过本发明的高效方法可高得率、高纯度地得到[(5,6-二羧基-3-吡啶)甲基]卤化铵。
通过用无机酸酸化反应混合物,并通过标准方法收集所得的式I产物可分离得到产物[(5,6-二羧基-3-吡啶)甲基]卤化铵。另一种方法是,将反应混合物整体用于制备最终除草剂的方法而不分离式I化合物。
上述Z、Z1、R4、R5、R6和R7的卤素例子是氟、氯、溴和碘,氯较佳。
适用于本发明方法的碱水溶液包括碱金属氢氧化物,如氢氧化钠和氢氧化钾,碱土金属氢氧化物,如氢氧化钙,碱金属碳酸盐,如碳酸钠和碳酸钾,碱土金属碳酸盐,如碳酸钙,和它们的混合物。较好的碱水溶液包括氢氧化钠水溶液和氢氧化钾水溶液。
有利的是,式II的取代的(3-喹啉基甲基)卤化铵在碱水溶液中的溶解度很高。一般来说,较好的碱浓度约为35-65wt%,最好的约为40-60wt%。过去,某些喹啉在浓度直至约35wt%碱水溶液存在下用过氧化氢氧化(参见U.S.4,816,588)。但是,需要适用更高浓度的碱,因为它会减少废物水溶液的生成。本发明方法另一个优点是不需要水相溶混的共溶剂,因为取代的(3-喹啉基甲基)卤化铵在碱水溶液中的溶解度很高。
为了完成式II取代的(3-喹啉基甲基)卤化铵的完全氧化,需要最少为8摩尔当量过氧化氢。较好的是使用约8-60摩尔当量的30-50%过氧化氢水溶液,最好是使用约8-40摩尔当量30-50%过氧化氢水溶液以氧化式II化合物。
在本发明较好的方法中,R、R1和R2各自是C1-C4烷基;
X是Cl或Br;
Z和Z1是氢;
R4、R5、R6和R7中的至少一个是羟基、硝基或OC(O)R8
R8是C1-C4烷基、C1-C4烷氧基或苯基。
在本发明最好的方法中,R、R1和R2是甲基;
X是Br;
R5、R6、R7、Z和Z1是氢;
R4是羟基、硝基或OC(O)R8
R8是C1-C4烷基或C1-C4烷氧基。
可这样制备式II的取代的(3-喹啉基甲基)卤化铵:在溶剂和任选地在催化量自由基引发剂存在下,用卤化剂卤化式III的取代的3-甲基喹啉,形成式IV的取代的3-卤代甲基喹啉,使式IV化合物与至少约1摩尔当量式V的胺在溶剂存在下反应。反应流程如下列流程I所示。
                           流程I
本发明也提供了制备具有下式的除草剂(5-烷氧基甲基)-2-(2-咪唑啉-2-基)-烟酸、酯和盐化合物的方法
Figure A9711361200091
其中Z和Z1的定义同上;
A是O或S;
R12是任意被苯基取代的C1-C4烷基,该苯基又任意被1-3个C1-C4烷基或卤原子所取代;或是
任意被1-3个C1-C4烷基或卤原子所取代的苯基;
R13是C1-C4烷基;
R14是C1-C4烷基、C3-C6环烷基,或R13和R14与相连的原子一起代表任意被甲基取代的C3-C6环烷基;
R15是氢、二低级烷基亚氨基,
任意被下列之一的基团取代的C1-C12烷基:C1-C3烷氧基、卤素、羟基、C3-C6环烷基、苄氧基、呋喃基、苯基、卤代苯基、低级烷基苯基、低级烷氧基苯基、硝基苯基、羧基、低级烷氧基羰基、氰基或三低级烷基铵;
任意被下列之一的基团取代的C3-C12链烯基:C1-C3烷氧基、苯基、卤素或低级烷氧基羰基,或是被两个C1-C3烷氧基或两个卤素取代的C3-C12链烯基;
任意被一个或两个C1-C3烷基取代的C3-C6环烷基;
或是阳离子,较好地是选自碱金属、碱土金属、锰、铜、铁、锌、钴、铅、银、镍、铵和有机铵的阳离子;和
当R13和R14代表不同的取代基时,还有其光学异构体;
该方法包括:
(a)用上述方法制备下式I化合物:
Figure A9711361200101
其中Z、Z1、R、R1、R2和X的定义同上;和
(b)将所述的式I化合物转化为式VI化合物。
上面涉及烷基和烷氧基所用的术语“低级”表示含1-6个,较好地含1-4个碳原子的烷基或烷氧基。
可用各种方法将式I化合物转化为式VI化合物。通过结合能将一种羧酸衍生物转化为另一种的反应,人们可以设计出反应途径。
用来制备咪唑啉酮除草剂的方法如“咪唑啉酮除草剂”一书所述,D.L.Shaner和S.L.O’Connor主编,CRC出版社(美国弗罗里达)于1991出版,具体是第2章名为“咪唑啉酮除草剂的合成”8-14页一文,以及其中引述的参考文献。下列专利文献也揭示了可用来将羧酸衍生物转化为咪唑啉酮最终产物的方法:
美国专利5,378,843;5,371,229;5,520,694;5,110,930;5,122,608;5,206,368;4,925,944;4,921,961;4,959,476;5,103,009;4,816,588;4,757,146;4,798,619;4,766,218;5,001,254;5,021,078;4,723,011;4,709,036;4,658,030;4,608,079;4,719,303;4,562,257;4,518,780;4,474,962;4,623,726;4,750,978;4,638,068;4,439,607;4,459,408;4,459,409;4,460,776;4,125,727和4,758,667,以及欧洲专利申请号EP-A-0-041-623;EP-A-0-331,899和EP-A-0-388,619。
为了易于进一步理解本发明,下列实施例仅供阐述更特定的细节用。本发明的范围不为这些实施例所限制,而由权利要求书来定义。
               实施例1[(5,6-二羧基-3-吡啶基)甲基]三甲基溴化铵的制备
Figure A9711361200111
在85-90℃下于15分钟内将过氧化氢溶液(20克,30wt%,12当量)加入搅拌着的[(8-乙酰氧基-3-喹啉基)甲基]三甲基溴化铵(5.0g,14.7毫摩尔)溶液和氢氧化钠溶液(9.4g,50wt%,8当量)。所得的反应混合物在85-90℃下搅拌90分钟,在85℃下再用过氧化氢溶液(26克,30wt%,15.6当量)处理30分钟,在85-90℃下搅拌一小时。LC分析最终的反应混合物表示标题产物的得率为80%。
                实施例2-4
用与实施例1基本相同的过程,但使用各种[(8-取代-3-喹啉基)-甲基]三甲基溴化胺得到了如表1所示的[(5,6-二羧基-3-吡啶基)甲基]三甲基溴化铵。
        表      I[(5,6-二羧基-3-吡啶基)甲基]三甲基溴化铵的制备
Figure A9711361200121
  实施例     R4 50wt%NaOH溶液的当量 30wt%H2O2溶液的当量 在85-90℃下搅拌的小时 I的得率%1
    2  OH     8     38     1.83     86
    3  OCO2CH3     9.8     58     1.75     83
    4  NO2     8     32     2.58     45
1LC分析反应混合物
      实施例58-乙酰氧基-3-甲基喹啉的制备
Figure A9711361200122
在0-10℃下用乙酸酐(208克,2.04摩尔)处理8-羟基-3-甲基喹啉(200克,1.02摩尔)和氢氧化钠(102克,2.55摩尔)在水(1000毫升)中的混合物达1小时,在室温下搅拌1小时。再加入乙酸酐(50克,0.49摩尔),所得的混合物搅拌一小时,用饱和碳酸氢钠溶液(100毫升)处理,过滤得到固体。固体用水洗涤,60℃真空烘箱内干燥,用乙酸乙酯/庚烷溶液重结晶得到白色针状的标题产物(168.5g,82%得率)。
      实施例68-苯甲酰氧基-3-甲基喹啉的制备
Figure A9711361200131
在0-10℃下,于1小时内用苯甲酰氯(10.8g,0.077摩尔)处理8-羟基-3-甲基喹啉(10克,0.051摩尔)和三乙胺(15.5g,0.15摩尔)在二氯甲烷中的混合物,在室温下搅拌三小时,用水稀释。分离各相,有机相用水洗涤,用无水硫酸镁干燥,真空浓缩得到固体。固体用庚烷/甲苯溶液重结晶得到淡黄色晶体的标题产物(8.8g,得率65%)。
              实施例7[(8-乙酰氧基-3-喹啉基)甲基]三甲基溴化铵的制备
Figure A9711361200141
8-乙酰氧基-3-甲基喹啉(168.5g,0.84摩尔)、N-溴代琥珀酰亚胺(177.9g,1.00摩尔)和2,2’-偶氮二异丁腈(6.7g,0.04摩尔)在氯苯(1,675毫升)中的溶液用氮气冲洗,在氮气下加热到80-90℃达2小时,冷却到室温并过滤。在0-5℃下,滤液在丙酮(700毫升)中的混合物用三甲胺(75.4 g,1.28摩尔)处理,在5-10℃搅拌30分钟,在室温下搅拌1小时,过滤得到固体。固体用丙酮洗涤,在60℃的真空烘箱内干燥,得到白色固体的标题产物(180克,总得率63%)。
使用基本相同的内容,但用各种8-取代-3-甲基喹啉得到下列产物
Figure A9711361200151
      R4
OC(O)C6H5
  OC(O)OCH3
      NO2
         实施例8[(8-羟基-3-喹啉基)甲基]三甲基溴化铵
Figure A9711361200152
将[(8-乙酰氧基-3-喹啉基)甲基]三甲基溴化铵(5.0g,14.7毫摩尔)在甲醇中的溶液回流13.5小时,真空浓缩得到残留物。将残留物在60℃的真空烘箱内干燥得到米色固体的标题产物(4.4g,100%得率)。

Claims (10)

1.一种制备结构式I的[(5,6-二羧基-3-吡啶基)甲基]卤化铵的方法
其中R、R1和R2各自是C1-C4烷基,当结合在一起时,R和R1可形成任意被O、S或NR3间隔的5-元或6-元环;
R3是C1-C4烷基,
X是Cl、Br或I;
Z是氢或卤素;和
Z1是氢、卤素、氰基或硝基,
该方法包括在碱水溶液存在下用过氧化氢使结构式II的取代的(3-喹啉基甲基)卤化铵氧化
Figure A9711361200022
其中R、R1、R2、X、Z和Z1的定义与上式I的相同;
R4、R5、R6和R7各自是氢、羟基、硝基、OC(O)R8、卤素、NR9R10、C1-C4烷氧基、SO3H、SO2Cl或SH,条件是R4、R5、R6和R7中的一个不是氢或卤素;
R8是C1-C4烷基、C1-C4烷氧基、苯基或NR11R12
R9、R10、R11和R12各自是氢、C1-C4烷基或苯基;
它的N-氧化物;和
它的酸加成盐。
2.根据权利要求1所述的方法,其中R、R1和R2各自是C1-C4烷基;
X是Cl或Br;
Z和Z1是氢;
R4、R5、R6和R7中的至少一个是羟基、硝基或OC(O)R8
R8是C1-C4烷基、C1-C4烷氧基或苯基。
3.根据权利要求1所述的方法,其中R、R1和R2是甲基;
X是Br;
R5、R6、R7、Z和Z1是氢;
R4是羟基、硝基或OC(O)R8
R8是C1-C4烷基或C1-C4烷氧基。
4.根据权利要求1所述的方法,其中过氧化氢的存在量相对于式II的取代的(3-喹啉基甲基)卤化铵为8-60摩尔当量。
5.根据权利要求1所述的方法,其中碱水溶液的存在量相对于式II的取代的(3-喹啉基甲基)卤化铵至少为1摩尔当量。
6.根据权利要求5所述的方法,其中碱水溶液的存在量为4-10摩尔当量。
7.根据权利要求1所述的方法,其中碱水溶液是氢氧化钠水溶液或氢氧化钾水溶液。
8.根据权利要求1所述的方法,其中式II的取代的(3-喹啉基甲基)卤化铵用过氧化氢在碱水溶液存在下在50-100℃温度范围里氧化。
9.根据权利要求8所述的方法,其中温度为75-95℃。
10.一种制备具有下式VI的除草剂咪唑啉酮化合物的方法:其中Z和Z1的定义与权利要求1的相同;
A是O或S;
R12是任意被苯基取代的C1-C4烷基,该苯基又任意被1-3个C1-C4烷基或卤原子所取代;或是
任意被1-3个C1-C4烷基或卤原子所取代的苯基;
R13是C1-C4烷基;
R14是C1-C4烷基、C3-C6环烷基,或R13和R14与相连的原子一起代表任意被甲基取代的C3-C6环烷基;
R15是氢、二低级烷基亚氨基,
任意被下列之一的基团取代的C1-C12烷基:C1-C3烷氧基、卤素、羟基、C3-C6环烷基、苄氧基、呋喃基、苯基、卤代苯基、低级烷基苯基、低级烷氧基苯基、硝基苯基、羧基、低级烷氧基羰基、氰基或三低级烷基铵;
任意被下列之一的基团取代的C3-C12链烯基:C1-C3烷氧基、苯基、卤素或低级烷氧基羰基,或是被两个C1-C3烷氧基或两个卤素取代的C3-C12链烯基;
任意被一个或两个C1-C3烷基取代的C3-C6环烷基;
或是阳离子,和
当R13和R14代表不同的取代基时,还有其光学异构体;
该方法包括:
(a)用权利要求1所述的方法制备下式I化合物:
Figure A9711361200041
其中Z、Z1、R、R1、R2和X的定义与权利要求1中的相同;和(b)将所述的式I化合物转化为式VI化合物。
CN97113612A 1996-06-10 1997-06-10 [(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法 Expired - Fee Related CN1100758C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66120696A 1996-06-10 1996-06-10
US08/661,206 1996-06-10
US08/661206 1996-06-10

Publications (2)

Publication Number Publication Date
CN1172802A true CN1172802A (zh) 1998-02-11
CN1100758C CN1100758C (zh) 2003-02-05

Family

ID=24652621

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97113612A Expired - Fee Related CN1100758C (zh) 1996-06-10 1997-06-10 [(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法

Country Status (28)

Country Link
US (1) US6002012A (zh)
EP (1) EP0812828B1 (zh)
JP (1) JPH1059941A (zh)
KR (1) KR980002026A (zh)
CN (1) CN1100758C (zh)
AR (1) AR007523A1 (zh)
AT (1) ATE214370T1 (zh)
AU (1) AU709900B2 (zh)
BR (1) BR9703506A (zh)
CA (1) CA2207379A1 (zh)
CO (1) CO5040015A1 (zh)
CZ (1) CZ288272B6 (zh)
DE (1) DE69710948T2 (zh)
DK (1) DK0812828T3 (zh)
ES (1) ES2174185T3 (zh)
HU (1) HU218875B (zh)
IL (1) IL121032A (zh)
IN (1) IN183352B (zh)
NZ (1) NZ314904A (zh)
PL (1) PL320464A1 (zh)
PT (1) PT812828E (zh)
RU (1) RU2142943C1 (zh)
SG (1) SG50845A1 (zh)
SK (1) SK73897A3 (zh)
TR (1) TR199700476A2 (zh)
TW (1) TW426671B (zh)
YU (1) YU24197A (zh)
ZA (1) ZA975075B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355016B1 (en) 1997-03-06 2002-03-12 Medtronic Percusurge, Inc. Catheter core wire
US6190332B1 (en) 1998-02-19 2001-02-20 Percusurge, Inc. Core wire with shapeable tip

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB331899A (en) * 1929-03-08 1930-07-08 Heinrich Schluepmann Improvements in two-stroke cycle internal combustion engines
GB388619A (en) * 1932-05-26 1933-03-02 Sunsaloon Bodies Ltd Improvements in beading and cover strips particularly for use on vehicles
US4723011A (en) * 1985-10-28 1988-02-02 American Cyanamid Company Preparation of substituted and disubstituted-pyridine-2,3-dicarboxylate esters
EP0259687B1 (en) * 1986-09-12 1991-07-03 American Cyanamid Company Method for the preparation of pyridine-2,3-dicarboxylic acids
US4816588A (en) * 1986-09-12 1989-03-28 American Cyanamid Company Method for the preparation of pyridine-2,3-dicarboxylic acids
IL89142A (en) * 1988-03-10 1993-04-04 American Cyanamid Co Method for the sequential oxidation of substituted 8-hydroxyquinolines to produce substituted pyridine-2,3- dicarboxylic acids
US5369022A (en) * 1988-12-30 1994-11-29 American Cyanamid Company Method to improve the protection of crops from herbicidal injury
DK0388619T3 (da) * 1989-03-22 1994-10-03 American Cyanamid Co Fremgangsmåde til fremstilling af substituerede 2,3-pyridindicarboxylsyrer ved sekvensvis oxidation af substituerede quinoliner
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids
EP0661268B1 (en) * 1993-12-28 1998-04-22 American Cyanamid Company Improved method for the preparation of pyridine-2,3-dicarboxylic acids
US5633380A (en) * 1995-06-05 1997-05-27 American Cyanamid Company Substituted quinoline herbicide intermediates and process
US5625068A (en) * 1995-06-05 1997-04-29 American Cyanamid Company Substituted quinoline herbicide intermediates and process

Also Published As

Publication number Publication date
BR9703506A (pt) 1998-10-06
AR007523A1 (es) 1999-11-10
ES2174185T3 (es) 2002-11-01
HU218875B (hu) 2000-12-28
CZ288272B6 (en) 2001-05-16
CZ170697A3 (en) 1997-12-17
CA2207379A1 (en) 1997-12-10
PT812828E (pt) 2002-09-30
IN183352B (zh) 1999-11-27
DE69710948T2 (de) 2002-07-04
MX9704259A (es) 1998-07-31
IL121032A0 (en) 1997-11-20
KR980002026A (ko) 1998-03-30
HUP9701022A1 (hu) 1998-04-28
US6002012A (en) 1999-12-14
PL320464A1 (en) 1997-12-22
SK73897A3 (en) 1998-02-04
IL121032A (en) 2001-01-28
SG50845A1 (en) 1998-07-20
EP0812828A1 (en) 1997-12-17
AU709900B2 (en) 1999-09-09
ZA975075B (en) 1998-12-09
HU9701022D0 (en) 1997-08-28
CN1100758C (zh) 2003-02-05
CO5040015A1 (es) 2001-05-29
ATE214370T1 (de) 2002-03-15
TR199700476A2 (xx) 1997-12-21
TW426671B (en) 2001-03-21
RU2142943C1 (ru) 1999-12-20
EP0812828B1 (en) 2002-03-13
JPH1059941A (ja) 1998-03-03
YU24197A (sh) 2000-12-28
DE69710948D1 (de) 2002-04-18
NZ314904A (en) 1998-06-26
DK0812828T3 (da) 2002-07-01
AU2475897A (en) 1997-12-18

Similar Documents

Publication Publication Date Title
CN1187343C (zh) 制备三唑啉硫酮衍生物的方法
IL173000A0 (en) Process for preparation of 4-aryl-nicotinamide derivatives
CN106905398B (zh) 一种索非布韦的合成方法
CN1958593A (zh) 一种用于合成瑞舒伐他汀钙的中间体的制备方法
CN100343259C (zh) 制备3-丙烯基头孢菌素dmf溶剂化物的方法
CN1100758C (zh) [(5,6-二羧基-3-吡啶基)甲基]卤化铵的制备方法
CN1027813C (zh) 接续氧化取代的8-羟基喹啉而制备取代的吡啶-2,3-二羧酸的方法
CN1105105C (zh) 制备作为杀虫剂中间体2-(吡啶-2-基氧基甲基)苯乙酸酯类化合物的方法
CN1039423A (zh) 2,2-脱水-1-(β-D-阿糖呋喃基)胸腺嘧啶的制备方法
CN1409700A (zh) 制备具有抗肥胖和抗糖尿病性质的芳基乙醇胺衍生物的方法
CN1068882C (zh) 5-(烷氧基甲基)-2,3-吡啶二甲酰亚胺化合物的制备方法
CN1683351A (zh) 环氧香紫苏醇的合成方法
CN109574830B (zh) 一种瑞舒伐他汀钙中间体及其制备方法和应用
CN1096450C (zh) 制备苯氧基丙酸衍生物的方法
CN1031695A (zh) 羟基芳族和氨基芳族化合物的碘化方法
CN112661705A (zh) 一种阿伐那非杂质的合成方法
CN1073111C (zh) 2,3-吡啶二甲酰亚胺的制备方法
CN1264823C (zh) 逆转录病毒蛋白酶抑制剂的制备方法及其中间体
CN1235891C (zh) 取代的烷基胺衍生物的生产方法
CN1708501A (zh) 制备氯甲基头孢烯衍生物的改进方法
CN1569842A (zh) 制备六氢哒嗪-3-羧酸衍生物的方法
CN1300133C (zh) (3r,5r)-3-羟基-5-氨乙基环戊内酯的合成方法
CN1115333C (zh) 生产2-磺酰基吡啶衍生物和生产2-{[(2-吡啶基)甲基]硫基}-1h-苯并咪唑衍生物的方法
CN1245803A (zh) 制备取代的吡啶类的方法
CN114805218A (zh) 一种瑞舒伐他汀钙中间体的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee